CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-α

Biochemical and Biophysical Research Communications

Volumn 387, Issue 1, 2009, Pages 139-142

  Guo, Xiaohuan ^a   Li, Ting ^a   Wang, Yu ^a   Shao, Luning ^a   Zhang, Yingmei ^a   Ma, Dalong ^a   Han, Wenling ^a  

^a Neuroscience Research Institute   (China)

Author keywords

Apoptosis; CMTM5; Pancreatic cancer; TNF

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINE; CMTM5 PROTEIN; DNA; KRUPPEL LIKE FACTOR 5; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CMTM5 GENE; DNA METHYLATION; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINES; DNA METHYLATION; GENE SILENCING; HUMANS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

AGOUTI PACA;

EID: 67651020742     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.148     Document Type: Article

References (12)

1. Han W., Ding P., Xu M., Wang L., Rui M., Shi S., Liu Y., Zheng Y., Chen Y., Yang T., and Ma D. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics 81 (2003) 609-617
2. Han W., Lou Y., Tang J., Zhang Y., Chen Y., Li Y., Gu W., Huang J., Gui L., Tang Y., Li F., Song Q., Di C., Wang L., Shi Q., Sun R., Xia D., Rui M., Tang J., and Ma D. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 357 (2001) 127-135
3. Shao L., Cui Y., Li H., Liu Y., Zhao H., Wang Y., Zhang Y., Ng K.M., Han W., Ma D., and Tao Q. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin. Cancer. Res. 13 (2007) 5756-5762
4. Shao L., Guo X., Plate M., Li T., Wang Y., Ma D., and Han W. CMTM5-v1 induces apoptosis in cervical carcinoma cells. Biochem. Biophys. Res. Commun. 379 (2009) 866-871
5. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
6. Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35 (2007) 495-516
7. Michl P., Barth C., Buchholz M., Lerch M.M., Rolke M., Holzmann K.H., Menke A., Fensterer H., Giehl K., Lohr M., Leder G., Iwamura T., Adler G., and Gress T.M. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63 (2003) 6265-6271
8. Nawrocki S.T., Carew J.S., Pino M.S., Highshaw R.A., Dunner Jr. K., Huang P., Abbruzzese J.L., and McConkey D.J. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 65 (2005) 11658-11666
9. Bai J., Sui J., Demirjian A., Vollmer Jr. C.M., Marasco W., and Callery M.P. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res. 65 (2005) 2344-2352
10. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 14 (2002) 477-492
11. Papa S., Bubici C., Zazzeroni F., Pham C.G., Kuntzen C., Knabb J.R., Dean K., and Franzoso G. The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13 (2006) 712-729
12. Gesierich S., Paret C., Hildebrand D., Weitz J., Zgraggen K., Schmitz-Winnenthal F.H., Horejsi V., Yoshie O., Herlyn D., Ashman L.K., and Zoller M. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin. Cancer Res. 11 (2005) 2840-2852